Number, type, and availability of new drugs are on the increase in EuropeBMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f3489 (Published 29 May 2013) Cite this as: BMJ 2013;346:f3489
- Rory Watson
Europe’s drugs scene is evolving as the use of established illicit substances such as heroin declines, but the number, type, and availability of new drugs continues to increase. The new challenges facing policy makers are set out in the latest annual report from the Lisbon based European Monitoring Centre for Drugs and Drug Addiction.1
The report confirms fewer new users of heroin, less injecting, and declining use of cannabis and cocaine in some European countries. However, cannabis use remains high by historical standards: some 77 million European adults have …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial